We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MedinCell S.A., a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France. The company develops solutions based on BEPO, a long-acting injectable technology. It offers UZEDY (mdc-IRM) for the treatment of schizophreni... MedinCell S.A., a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France. The company develops solutions based on BEPO, a long-acting injectable technology. It offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults and bipolar I disorder. It is also developing mdc-TJK, a subcutaneous injection that is in the NDA preparation stage for the treatment of schizophrenia in adults; and mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation in total knee arthroplasty surgery. In addition, its product candidates in preclinical trials include mdc-WWM for contraception; and mdc-STM for malaria. It has strategic collaborations with AbbVie to develop, manufacture, and commercialize six long-acting injectable therapeutic products; and IM4TB to develop a long-acting injectable version of Macozinone for the treatment of tuberculosis. MedinCell S.A. was incorporated in 2003 and is based in Jacou, France. Show more
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 34.39 | 34.39 | 34.39 | 0 | 0 | CS |
| 26 | 27.4143 | 392.997118569 | 6.9757 | 34.39 | 6.9757 | 65 | 34.39 | CS |
| 52 | 27.4143 | 392.997118569 | 6.9757 | 34.39 | 6.9757 | 89 | 13.30207692 | CS |
| 156 | 27.4046 | 392.312537578 | 6.9854 | 34.39 | 6.9746 | 864 | 7.43389735 | CS |
| 260 | 20.39 | 145.642857143 | 14 | 34.39 | 6.9746 | 1387 | 9.20560969 | CS |
imanjen13
5 minutes ago
FormalMHRAconsultant
7 minutes ago
meixatech
7 minutes ago
havnagoodtime
12 minutes ago
sagedono
16 minutes ago
EternalGuru94
18 minutes ago
Eths
20 minutes ago
Dr RickL
22 minutes ago
Investorexpert
24 minutes ago
Investorexpert
24 minutes ago
Investorexpert
24 minutes ago
Investorexpert
25 minutes ago
Investorexpert
25 minutes ago
Investorexpert
26 minutes ago
Investorexpert
26 minutes ago
CryptoRain
27 minutes ago
Investorexpert
29 minutes ago
tramaine
30 minutes ago
Investorexpert
31 minutes ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Already have an account? Sign in
Don't have an account? Sign up
By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.